Allen Bott, MD
Neurology with Special Qualifications in Child Neurology · Oakland, CANPI 1770577652
Payments from drug & device makers
Across 563 payments — averaging $659.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$144K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$60K
- AbbVie$46K
- Axsome Therapeutics, Inc.$39K
- Otsuka America Pharmaceutical, Inc.$24K
- Eisai Inc.$23K
- plus $36K from 14 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 175 | $143,576 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 78 | $60,110 |
| AbbVie(2 entities) | 109 | $46,417 |
| Axsome Therapeutics, Inc. | 50 | $39,027 |
| Otsuka America Pharmaceutical, Inc. | 42 | $23,559 |
| Eisai Inc. | 27 | $22,661 |
| Teva Pharmaceuticals USA, Inc. | 37 | $19,164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $14,876 |
| Sunovion Pharmaceuticals Inc. | 7 | $1,552 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $274 |
| E.r. Squibb & Sons, L.L.C. | 2 | $63 |
| Biogen | 3 | $61 |
| Lundbeck LLC | 2 | $53 |
| Amneal Pharmaceuticals LLC | 1 | $30 |
| Acadia Pharmaceuticals Inc | 1 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Amgen | 1 | $26 |
| Avanir Pharmaceuticals, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $14 |
| Impel Pharmaceuticals Inc. | 1 | $12 |
How this compares
$371,554 in reported general payments places this provider in the 90th percentile of 216 neurology with special qualifications in child neurology providers in California.
See all neurology with special qualifications in child neurology providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in Oakland
- Ali MostajeleanOakland$168K
- Rachel KupermanOakland$132K
- Sabine MuellerSan Francisco$17.5M
- Joseph SullivanSan Francisco$1.7M
- Rajsekar RajaramanLos Angeles$1.5M
- Jonathan SantoroPalo Alto$1.5M
- Michelle MonjePalo Alto$1.3M
- Jay DesaiLos Angeles$1.2M
- Richard HaasSan Diego$1.2M
- Leigh Maria Ramos PlattLos Angeles$981K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.